A Study to Evaluate Efficacy and Safety of Glinib in Newly Diagnosed CML Patients
Clinical trial NCT02204722 · TERMINATED
Trial details
- NCT number
- NCT02204722
- Sponsor
- Dong-A ST Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-13
- Primary completion
- 2017-05-23
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.